Breaking News

Generic Specialties Acquires Axcellerate Pharma

Allows the company to move into the injectables market

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Generic Specialties has acquired Axcellerate Pharma, a contract research organization and contract development and manufacturing organization (CRO/CDMO) focused on the development and manufacturing of sterile injectable products for generics and biologics. Axcellerate Pharma, a specialty pharmaceutical and biologics contract manufacturer with an emphasis on clinical trials to commercial-scale manufacturing of sterile liquid, lyophilized parenterals, injectables and biologics, purchased the fa...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters